Jilin Yezheng Biological Products Co., Ltd. has total assets of 65.438+0.77 billion yuan, covers an area of 65.438+0.45 million square meters, and employs 297 people, including 23 graduate students with bachelor degree or above. Senior technical title 13, intermediate title 39. The company is mainly engaged in veterinary biological products, diagnostic reagents and project investment. It is a veterinary biological product enterprise integrating R&D, production and sales, with an annual production capacity of 654.38+0.8 billion feathers (ml, head). In June 2006, it was recognized as a "high-tech enterprise" by the Science and Technology Department of Jilin Province.
Jilin Yezheng Biological Products Co., Ltd. is the first batch of enterprises designated by the Ministry of Agriculture to produce highly pathogenic inactivated vaccine of porcine blue ear disease and purified freeze-dried inactivated vaccine of rabies (Flury LEP strain), and it is also the enterprise designated by the Ministry of Agriculture to produce attenuated vaccine of classical swine fever. At present, three production workshops and nine production lines have passed the GMP certification of the Ministry of Agriculture, and the products cover more than 60 varieties in five series. There is an SPF henhouse with an annual output of breeding eggs1.2000.
Jilin Yezheng Biological Products Co., Ltd. won a number of national or provincial scientific and technological awards: refined freeze-dried inactivated rabies vaccine for human use (Flury LEP strain) was awarded the "New Veterinary Drug Certificate" by the Ministry; Virulent live vaccines such as bursa of fabricius were awarded the "new drug certificate" by the Ministry; Live swine fever vaccine was awarded the title of "quality product" by the Ministry; The self-developed live rabies vaccine is the only product recognized by the state to prevent rabies in China, which fills the gap in China. From 2004 to 2006, the company was awarded the "National Key New Product Certificate" by the Ministry of Science and Technology, the Ministry of Commerce, the General Administration of Quality Supervision, Inspection and Quarantine and the State Environmental Protection Administration.
Jilin Yezheng Biological Products Co., Ltd. actively seeks cooperation while insisting on independent research and development, and realizes a win-win situation with the help of external forces. In recent years, we have established cooperative relations with Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Shanghai Veterinary Research Institute, Changchun Military Veterinary Research Institute, Jilin University, China Agricultural University, Jilin Agricultural University and other universities and scientific research institutions. , jointly carry out research on new products, new technologies and new processes.
In 2008, the company signed a strategic cooperation agreement with Shanghai Veterinary Research Institute of Chinese Academy of Agricultural Sciences and reached a long-term partnership. Cooperate with Beijing Supervision Institute to develop and purify freeze-dried inactivated rabies vaccine (Flury LEP strain); In June, 2009, 5438+February, it was jointly researched and developed with Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, and developed a highly pathogenic porcine blue ear disease vaccine (HuN4-F 1 12 strains), which reserved the follow-up force for the product upgrade of enterprises.
"Science and technology give birth to high-quality products, and quality leads legitimate business". Jilin Yezheng will continue to contribute to the prevention and control of animal diseases, the protection of human food safety and the healthy development of animal husbandry with the best quality products and services, and "join in animal protection and protect the prosperity of six livestock"!